UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis

JAMA surgery, 2017-08, Vol.152 (8), p.e171538

2017

Volltextzugriff (PDF)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials

British journal of dermatology (1951), 2017-04, Vol.176 (4), p.890-901

2017

Volltextzugriff (PDF)

Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan

PloS one, 2020-12, Vol.15 (12), p.e0244620

2020

Volltextzugriff (PDF)

Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.594-603

2017

Volltextzugriff (PDF)

Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis

Medicine (Baltimore), 2021-10, Vol.100 (40), p.e27368

2021

Volltextzugriff (PDF)

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.329-337

2019

Volltextzugriff (PDF)

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.643-649

2017

Volltextzugriff (PDF)

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization

Allergy (Copenhagen), 2015-07, Vol.70 (7), p.784-794

2015

Volltextzugriff (PDF)

Efficacy and safety of biological agents in adult-onset Still's disease

Scandinavian journal of rheumatology, 2015-07, Vol.44 (4), p.309-314

2015

Volltextzugriff (PDF)

Current treatment options and safety considerations when treating adult-onset Still's disease

Expert opinion on drug safety, 2020-12, Vol.19 (12), p.1549-1558

2020

Volltextzugriff (PDF)

The effect of immune therapy on surgical site infection following Crohn's Disease resection

British journal of surgery, 2013-07, Vol.100 (8), p.1089-1093

2013

Volltextzugriff (PDF)

Dermpath and Clinic: How to manage adverse reactions to biological agents

EJD. European journal of dermatology, 2021-06, Vol.31 (3), p.426-427

2021

Volltextzugriff (PDF)

Paradoxical hidradenitis suppurativa to biologic agents: a case series and literature review

International journal of dermatology, 2019-11, Vol.58 (11), p.e226-e228

2019

Volltextzugriff (PDF)

Rituximab-induced lung disease: a systematic literature review

The European respiratory journal, 2010-03, Vol.35 (3), p.681-687

2010

Volltextzugriff (PDF)

Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials

Medicine (Baltimore), 2020-07, Vol.99 (31), p.e21447

2020

Volltextzugriff (PDF)

Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics

EJD. European journal of dermatology, 2021-08, Vol.31 (4), p.493-498

2021

Volltextzugriff (PDF)

nab -Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Cancer treatment reviews, 2014-06, Vol.40 (5), p.614-625

2014

Volltextzugriff (PDF)

Global oncofertility index—data gap slows progress

Biology of reproduction, 2017-06, Vol.96 (6), p.1124-1128

2017

Volltextzugriff (PDF)

Biological treatments for moderate-to-severe psoriasis: indirect comparison

Journal of clinical pharmacy and therapeutics, 2013-04, Vol.38 (2), p.121-130

2013

Volltextzugriff (PDF)

Biologic treatment of recalcitrant pediatric psoriasis: a case series from a tertiary medical center

The Journal of dermatological treatment, 2019-02, Vol.30 (2), p.152-155

2019

Volltextzugriff (PDF)

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration

Journal of bone and joint surgery. American volume, 2006-03, Vol.88 (3), p.503

2006

Volltextzugriff (PDF)

Computerized physician order entry‐based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project

Hepatology (Baltimore, Md.), 2014-07, Vol.60 (1), p.106-113

2014

Volltextzugriff (PDF)

Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry

Arthritis care & research (2010), 2016-12, Vol.68 (12), p.1888-1893

2016

Volltextzugriff (PDF)

Clinical investigation of nontuberculous mycobacterial lung disease in Japanese patients with rheumatoid arthritis receiving biologic therapy

Journal of rheumatology, 2013-12, Vol.40 (12), p.1994-2000

2013

Volltextzugriff (PDF)

Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study

Rheumatology (Oxford, England), 2016-06, Vol.55 (6), p.1017-1022

2016

Volltextzugriff (PDF)

1 – 25 von 46.142

Suche als RSS-Feed

Aktive Filter

SpracheRussisch

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43.567)
Mit Volltextzugriff
(36.269)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(46.139)
Biological And Medical Sciences
(44.382)
Medical Sciences
(43.084)
Science & Technology
(42.799)
Life Sciences & Biomedicine
(42.590)
Female
(39.089)
Male
(36.222)
Middle Aged
(33.861)
Risk Factors
(22.199)
Aged
(22.115)
Time Factors
(16.656)
Adolescent
(12.563)
Pharmacology. Drug Treatments
(10.160)
Treatment Outcome
(7.897)
Aged, 80 And Over
(7.700)
Retrospective Studies
(7.669)
Surgery
(6.538)
Oncology
(6.298)
Follow-Up Studies
(6.169)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(46.140)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(29.805)
Ingenta Connect
(23.278)
EZB Electronic Journals Library
(20.077)
NUS Single-Journal Subscriptions
(13.415)
IngentaConnect Journals
(12.709)
Elsevier ScienceDirect Journals Complete
(10.189)
Wiley Online Library Journals
(7.971)
Wiley Online Library Full Collection 2018
(6.831)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(5.977)
Oxford journals
(3.999)
SpringerLink
(3.642)
Oxford Journals 2020 Medicine
(3.411)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(3.038)
JSTOR
(2.416)
Nature Journals
(2.094)
BMJ Publishing
(1.615)
Nexis Uni
(1.529)
BMJ Journals Archiv - DFG Nationallizenzen
(1.471)
Taylor & Francis Journals Complete
(1.462)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(1.028)
Transplantation Proceedings
(864)
Journal Of Clinical Oncology
(712)
American Journal Of Epidemiology
(680)
Occupational And Environmental Medicine
(600)
Transplantation
(579)
Cancer
(478)
International Journal Of Cancer
(398)
American Journal Of Industrial Medicine
(395)
Blood
(376)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials

Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan

Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis

Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization

Efficacy and safety of biological agents in adult-onset Still's disease

Current treatment options and safety considerations when treating adult-onset Still's disease

The effect of immune therapy on surgical site infection following Crohn's Disease resection

Dermpath and Clinic: How to manage adverse reactions to biological agents

Paradoxical hidradenitis suppurativa to biologic agents: a case series and literature review

Rituximab-induced lung disease: a systematic literature review

Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials

Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics

nab -Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Global oncofertility index—data gap slows progress

Biological treatments for moderate-to-severe psoriasis: indirect comparison

Biologic treatment of recalcitrant pediatric psoriasis: a case series from a tertiary medical center

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration

Computerized physician order entry‐based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project

Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry

Clinical investigation of nontuberculous mycobacterial lung disease in Japanese patients with rheumatoid arthritis receiving biologic therapy

Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study

Aktive Filter

Suchergebnisse filtern